RxDoctor Payments Data

Kristen Campbell

Family · Melbourne, FLNPI 1639514698

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.6% of the total across 486 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,087in general payments, 2019–2025

Across 486 payments — averaging $24.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$984
  • Regeneron Healthcare Solutions, Inc.$864
  • Dermavant Sciences, Inc.$845
  • Novartis$813
  • Lilly USA, LLC$791
  • plus $6K from 27 others

What the payments were for

  • Food & beverage$11,55896%
  • Education$5294%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,087 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.

See all family providers in Florida →

Medicare billing

Part B allowed, 2024
$207,007
Medicare patients
551
Services billed
4,090

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab17$61,982
Fluorouracil23$1,280
Clobetasol Propionate16$924
Ketoconazole38$840
Betamethasone Dipropionate13$759
Fluocinonide19$468
Triamcinolone Acetonide35$419
ValacyclovirValacyclovir Hcl11$303
Mometasone Furoate11$277
Hydrocortisone16$140
Mupirocin15$100

Paid to pharmacies, not to this prescriber.

Other family in Melbourne

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →